GPCR

Structure Therapeutics (GPCR)

About Structure Therapeutics (GPCR)

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Details

Daily high

$46.29

Daily low

$43.98

Price at open

$44.93

52 Week High

$94.90

52 Week Low

$15.80

Market cap

3.2B

Dividend yield

0.00%

Volume

650,405

Avg. volume

792,158

P/E ratio

-16.91

Structure Therapeutics News